Gene · 359
Papers3,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,878
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical characteristics and outcomes of hyponatraemia associated with oral water intake in adults: a systematic review. | BMJ Open | 2021 | 34887267 | PubTator, text mining | PubMed |
| The Extracellular Matrix Environment of Clear Cell Renal Cell Carcinoma Determines Cancer Associated Fibroblast Growth. | Cancers (Basel) | 2021 | 34884982 | PubTator, text mining | PubMed |
| Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. | Int J Mol Sci | 2021 | 34884753 | PubTator, text mining | PubMed |
| Apelin and Vasopressin: The Yin and Yang of Water Balance. | Front Endocrinol (Lausanne) | 2021 | 34880830 | PubTator, text mining | PubMed |
| Vasopressin and Breathing: Review of Evidence for Respiratory Effects of the Antidiuretic Hormone. | Front Physiol | 2021 | 34867449 | PubTator, text mining | PubMed |
| Topiramate-induced severe electrolyte abnormalities and hypernatremia leading to central pontine myelinolysis. | BMJ Case Rep | 2021 | 34848414 | PubTator, text mining | PubMed |
| [Clinical characteristics and molecular genetics of seven neonates with congenital nephrogenic diabetes insipidus]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2021 | 34839503 | PubTator, text mining | PubMed |
| Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats. | Pharmaceutics | 2021 | 34834241 | PubTator, text mining | PubMed |
| Loss of Function of Mutant IDS Due to Endoplasmic Reticulum-Associated Degradation: New Therapeutic Opportunities for Mucopolysaccharidosis Type II. | Int J Mol Sci | 2021 | 34830113 | PubTator, text mining | PubMed |
| Peroxiporins Are Induced upon Oxidative Stress Insult and Are Associated with Oxidative Stress Resistance in Colon Cancer Cell Lines. | Antioxidants (Basel) | 2021 | 34829727 | PubTator, text mining | PubMed |
| Cardiorenal Syndrome: New Pathways and Novel Biomarkers. | Biomolecules | 2021 | 34827580 | PubTator, text mining | PubMed |
| Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations - A review. | Int J Cardiol Cardiovasc Risk Prev | 2021 | 34825245 | PubTator, text mining | PubMed |
| Transcriptome profiling of lncRNA and co-expression network in the vaginal epithelial tissue of women with lubrication disorders. | PeerJ | 2021 | 34824921 | PubTator, text mining | PubMed |
| Correction: Actin remodeling requires ERM function to facilitate AQP2 apical targeting. | J Cell Sci | 2021 | 34817053 | PubTator, text mining | PubMed |
| Heterogeneity of cell composition and origin identified by single-cell transcriptomics in renal cysts of patients with autosomal dominant polycystic kidney disease. | Theranostics | 2021 | 34815804 | PubTator, text mining | PubMed |
| Extracellular vesicles: Potential impact on cardiovascular diseases. | Adv Clin Chem | 2021 | 34809830 | PubTator, text mining | PubMed |
| Serum Alpha-1-Acid Glycoprotein-1 and Urinary Extracellular Vesicle miR-21-5p as Potential Biomarkers of Primary Aldosteronism. | Front Immunol | 2021 | 34804057 | PubTator, text mining | PubMed |
| Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice. | Pharmgenomics Pers Med | 2021 | 34803393 | PubTator, text mining | PubMed |
| Brain dysfunction in tubular and tubulointerstitial kidney diseases. | Nephrol Dial Transplant | 2021 | 34792176 | PubTator, text mining | PubMed |
| Therapeutic Targeting of SGLT2: A New Era in the Treatment of Diabetes and Diabetic Kidney Disease. | Front Endocrinol (Lausanne) | 2021 | 34790170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/359/papers?page=38